Edinburgh-based US healthcare specialist Craneware has updated its full-year market expectations, with revenue of $74m and adjusted earnings of $25.3m.
For the six months ended 31 December, increased sales momentum resulted in growth at both the revenue and adjusted earnings levels of greater than 5% compared to the first half of the prior year - when revenue was $35.9m and adjusted earnings stood at $12.7m.
The provider of pricing and billing systems to US hospitals reported "strong performance" against the ongoing backdrop of the pandemic and a volatile dollar exchange rate.
Its customer retention rate remained above 90% and the dollar renewal rate of customers at the end of their multi-year contracts has returned to approximately 100%.
Craneware stated that it continues to invest in the expansion of its cloud-based financial and operational performance platform Trisus, with capitalisation for research and development costs being maintained at broadly the same level as prior periods.
The group continues to find new sales opportunities, although chief executive Keith Neilson said he remains cognisant of ongoing macro uncertainties.
"But with a strong balance sheet, high levels of recurring revenue and expanding product offering, we are in a strong position as we enter the second half of the year.”
